The goal of this observational prospective study is to evaluate wound healing outcomes in resection wounds resulting from surgical removal of cutaneous malignancies treated with a synthetic electrospun fiber matrix. This study intends to quantify the time from initial resection and product application to time of complete granulation of the wound bed in weeks.
Patient is at least 18 years old
Patient plans to undergo surgical resection of a cutaneous neoplasm
Patient is willing and capable of complying with all protocol requirements
Patient or legally authorized representative (LAR) is willing to provide written informed consent prior to participation in study
Inability to give informed consent or to complete the procedures required for study completion
Patient has been previously enrolled into this study, or is currently participating in another drug or device study that has not reached its primary endpoint
Patient is pregnant, breast feeding or planning to become pregnant
Patient has a known allergy to resorbable suture materials, e.g. Polyglactin 910 (PGLA), Polydioxanone (PDS)